Safety by Design: Pre-IND Risk Considerations for In Vivo Gene Editing Programs
Genotoxicity, immunogenicity, off-target editing — a framework for building safety considerations into the LNP formulation screening process before animal studies begin.
Gendelivr's research team writes openly about LNP formulation science, computational screening methodology, and gene editing delivery challenges.
Technical articles on LNP biology, formulation strategy, delivery barriers, and computational screening methodology. 12 articles published.
Browse all articlesPeer-reviewed research contributions from the Gendelivr team. Published in collaboration with academic partner groups.
Coming in 2026Formulation screening guides, IND documentation checklists, and LNP characterization protocol summaries.
Available with accessGenotoxicity, immunogenicity, off-target editing — a framework for building safety considerations into the LNP formulation screening process before animal studies begin.
Base editors and prime editors are larger than standard SpCas9 constructs. How larger cargo size reshapes the LNP formulation optimization problem.
Only ~1-2% of endocytosed LNPs successfully escape to the cytoplasm. This post examines formulation levers that improve escape efficiency.